Total Payments
$19,775
2024 Payments
$2,439
Companies
40
Transactions
843
Medicare Patients
16,392
Medicare Billing
$2.2M
Payment Breakdown by Category
Food & Beverage$18,547 (93.8%)
Travel$1,180 (6.0%)
Education$48.10 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,547 | 835 | 93.8% |
| Travel and Lodging | $1,180 | 5 | 6.0% |
| Education | $48.10 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $4,422 | 90 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,176 | 113 | $0 (2024) |
| Amgen Inc. | $2,107 | 141 | $0 (2024) |
| PFIZER INC. | $1,374 | 78 | $0 (2024) |
| Boston Scientific Corporation | $970.60 | 47 | $0 (2024) |
| Edwards Lifesciences Corporation | $773.90 | 18 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $751.12 | 29 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $642.76 | 41 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $619.66 | 36 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $583.51 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,439 | 104 | Medtronic, Inc. ($285.55) |
| 2023 | $2,436 | 111 | Novartis Pharmaceuticals Corporation ($349.73) |
| 2022 | $2,066 | 91 | Abbott Laboratories ($488.21) |
| 2021 | $1,720 | 85 | Abbott Laboratories ($334.67) |
| 2020 | $1,200 | 64 | Amgen Inc. ($264.52) |
| 2019 | $4,606 | 149 | Abbott Laboratories ($2,019) |
| 2018 | $2,687 | 119 | Abbott Laboratories ($543.10) |
| 2017 | $2,621 | 120 | Novartis Pharmaceuticals Corporation ($447.41) |
All Payment Transactions
843 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Medtronic, Inc. | AZURE XT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: Pacemakers | ||||||
| 12/17/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Transcatheter Heart Valves | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: DIABETES | ||||||
| 12/06/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/06/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $5.55 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $25.40 | General |
| Category: Cardiovascular | ||||||
| 11/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: DIABETES | ||||||
| 11/20/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Transcatheter Heart Valves | ||||||
| 11/15/2024 | Boston Scientific Corporation | EMBLEM MRI S-ICD (Device) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: EMBLEM_CRM | ||||||
| 11/14/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/13/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $29.08 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $26.39 | General |
| 10/30/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Heart Failure | ||||||
| 10/30/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/29/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $16.39 | General |
| Category: Coronary | ||||||
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $5.77 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.64 | General |
| Category: Cardiovascular | ||||||
| 10/15/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $31.97 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/15/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $29.29 | General |
| Category: Not Applicable | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/10/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $41.64 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/08/2024 | Medtronic, Inc. | TYRX (Device) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: Antibacterial Mesh | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 4,235 | 18,824 | $2.7M | $606,926 |
| 2022 | 34 | 4,235 | 18,009 | $2.4M | $540,688 |
| 2021 | 36 | 4,084 | 18,303 | $2.5M | $583,136 |
| 2020 | 35 | 3,838 | 15,899 | $2.1M | $497,456 |
Total Patients
16,392
Total Services
71,035
Medicare Billing
$2.2M
Procedure Codes
152
All Medicare Procedures & Services
152 procedure records from CMS Medicare Utilization — Page 3 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 27 | 47 | $28,200 | $8,754 | 31.0% |
| 96374 | Injection of drug or substance into vein | Office | 2022 | 228 | 228 | $26,220 | $8,403 | 32.0% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2022 | 31 | 31 | $40,425 | $6,553 | 16.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 54 | 60 | $8,700 | $4,866 | 55.9% |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | Office | 2022 | 136 | 12,240 | $40,799 | $4,516 | 11.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 50 | 55 | $5,775 | $4,358 | 75.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 335 | 352 | $38,720 | $4,283 | 11.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 412 | 504 | $50,400 | $3,577 | 7.1% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2022 | 29 | 30 | $24,000 | $2,799 | 11.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 12 | $3,300 | $1,924 | 58.3% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2022 | 17 | 18 | $7,650 | $1,701 | 22.2% |
| 93226 | Electrocardiogram (ecg) 2-day continuous with report | Office | 2022 | 43 | 46 | $4,600 | $1,611 | 35.0% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2022 | 31 | 31 | $9,965 | $1,483 | 14.9% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2022 | 15 | 41 | $4,100 | $993.41 | 24.2% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2022 | 50 | 50 | $3,250 | $857.52 | 26.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 11 | 11 | $9,240 | $710.61 | 7.7% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2022 | 31 | 31 | $11,375 | $707.53 | 6.2% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2022 | 30 | 31 | $3,410 | $480.90 | 14.1% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2022 | 22 | 22 | $4,070 | $416.89 | 10.2% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Office | 2022 | 17 | 17 | $1,530 | $363.55 | 23.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2022 | 22 | 22 | $2,310 | $278.93 | 12.1% |
| 93270 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | Office | 2022 | 16 | 16 | $2,000 | $128.48 | 6.4% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2022 | 30 | 31 | $4,340 | $83.49 | 1.9% |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | Office | 2021 | 241 | 243 | $861,435 | $107,603 | 12.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 354 | 637 | $124,215 | $68,603 | 55.2% |
About Dr. Kristal Young, M.D
Dr. Kristal Young, M.D is a Internal Medicine healthcare provider based in Pasadena, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/03/2010. The National Provider Identifier (NPI) number assigned to this provider is 1053631960.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kristal Young, M.D has received a total of $19,775 in payments from pharmaceutical and medical device companies, with $2,439 received in 2024. These payments were reported across 843 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($18,547).
As a Medicare-enrolled provider, Young has provided services to 16,392 Medicare beneficiaries, totaling 71,035 services with total Medicare billing of $2.2M. Data is available for 4 years (2020–2023), covering 152 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Pasadena, CA
- Active Since 06/03/2010
- Last Updated 05/24/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1053631960
Products in Payments
- Mitra Clip system (Device) $2,135
- ENTRESTO (Drug) $1,703
- ELIQUIS (Drug) $1,451
- Repatha (Biological) $1,151
- Corlanor (Drug) $956.30
- XARELTO (Drug) $583.51
- LifeVest (Device) $563.73
- PRALUENT (Drug) $481.82
- LEQVIO (Drug) $472.86
- NEXLETOL (Drug) $397.60
- VYNDAQEL (Drug) $392.58
- JARDIANCE (Drug) $389.24
- VERQUVO (Drug) $343.58
- Pacemakers (Device) $340.47
- FARXIGA (Drug) $335.23
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $331.81
- BRILINTA (Drug) $323.46
- NORTHERA (Drug) $319.81
- CardioMEMS HF System (Device) $309.12
- Vascepa (Drug) $276.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pasadena
Dr. Yuan Yuan, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $523,801
Internal Medicine $523,801
Christopher Dagher, M.d, M.D
Internal Medicine — Payments: $103,615
Internal Medicine $103,615
Peter Haddad, M.d, M.D
Internal Medicine — Payments: $87,600
Internal Medicine $87,600
Dr. Andrew Williams, M.d, M.D
Internal Medicine — Payments: $85,273
Internal Medicine $85,273
Joseph Dellinger, Md, MD
Internal Medicine — Payments: $77,175
Internal Medicine $77,175
Dr. Helen Moon, M.d, M.D
Internal Medicine — Payments: $61,882
Internal Medicine $61,882